This compound is a pharmaceutical intermediate used in the manufacturing process of baloxavir marboxil. It is a linear molecule containing an amine and three ether functional groups, indicating moderate polarity and the ability to participate in hydrogen bonding.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1228258-40-9
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
pharmaceutical intermediate
1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(phenylmethoxy)-, (12aR)-
pharmaceutical intermediate
Battery Park City Authority
pharmaceutical intermediate
Glycyl-L-prolyl-L-glutaminylglycyl-L-prolyl-L-glutamine
pharmaceutical intermediate
1H-Benzimidazole-2-butanoic acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, 2-((2-(3-carboxypropyl)-1-methyl-1H-benzimidazol-5-yl)(2-chloroethyl)amino)ethyl ester
pharmaceutical intermediate
Boc-(s)-2-amino-2-(3-bromophenyl)acetic acid
pharmaceutical intermediate
1-Cbz-4-hydroxymethylpiperidine
pharmaceutical intermediate
2-(2,2-dimethoxyethoxy)ethanamine
CBEGMMFTEUNTQO-UHFFFAOYSA-N
COC(COCCN)OC